"At the end of six months, those who had taken just one dose of psilocybin had more than six times greater odds of being abstinent from cigarettes than their counterparts who relied on the nicotine substitute. Everyone in the study also underwent cognitive behavioral therapy for smoking cessation over the course of 13 weeks."
"I was surprised by the sheer magnitude of the effect, says Matthew Johnson, the study's author and a professor of psychiatry at Johns Hopkins. The findings, published in the medical journal JAMA Network Open on Tuesday, came from a sample of 82 current smokers, who were randomly separated into two groups."
"Similar to other psychedelic trials, the participants had support from facilitators to make sure they were comfortable and prepared for their trip. They ingested a relatively high dose of pure psilocybin. While under the influence, they lay in a room wearing eye shades and listening to soft music, but their overall experience was self-directed."
A Johns Hopkins University study demonstrates psilocybin's potential for treating nicotine addiction, the leading cause of preventable death in the U.S. Researchers compared a single psilocybin dose with nicotine patches in 82 smokers who also received 13 weeks of cognitive behavioral therapy. After six months, participants receiving psilocybin showed more than six times greater odds of smoking abstinence compared to the nicotine patch group. During the psilocybin session, participants remained in a comfortable environment with eye shades and soft music while facilitators provided support. The magnitude of psilocybin's effect surprised researchers, suggesting psychedelics may offer significant advantages in addiction treatment beyond mental health applications.
Read at www.npr.org
Unable to calculate read time
Collection
[
|
...
]